Cctu

This study tests whether adding a stronger chemotherapy regimen (FOLFOXIRI) to standard chemoradiotherapy helps eliminate more cancer before surgery in people with high-risk locally advanced rectal cancer. About 72 participants will receive either standard treatment or the intens…

This study tests a drug called pembrolizumab in 30 people with liver cancer caused by hepatitis B. The drug helps the immune system fight cancer. Researchers will check if tumors shrink and how the immune system changes during treatment. Participants must have stable hepatitis B …

This study compares two types of radiation therapy for men with high-risk prostate cancer that has not spread. One group gets standard radiation (38 sessions over 8 weeks) and the other gets a shorter course (5 sessions over 5 weeks). Both groups also receive hormone therapy. The…